Friday 6 November 2026 Export BLLN’s income statement to Excel — free account

BillionToOne, Inc.

BLLN Healthcare Diagnostics & Research

BillionToOne, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $305.1 million, up 100.0% from fiscal 2024.

Revenue: +47.2%
EPS: +164.3%
Free cash flow: +9.25%
Total debt: +60.6%

Quarter to September 2026, against a year earlier

111.54 0.85 −0.76%

Follow BLLN

Alert me

Market cap: $5.3B
P/E: 88.7×
Fwd P/E: 146×
Dividend yield: —
F-score: n/a
Altman Z: 6.04
Beneish M: −2.03
Dividend safety: n/a

Overview

BillionToOne, Inc. (BLLN) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, BillionToOne, Inc. (BLLN) trades at a P/S ratio of 12.1×. Over the past ten years it has ranged from 3.3× (March 2026) to 17.5× (August 2026); the current reading is higher than 75% of that period. That is above the Diagnostics & Research industry median of 4.2× and above the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/BLLN/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="BillionToOne, Inc. P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/BLLN/metrics/ps-ratio">BillionToOne, Inc. (BLLN) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	4.3×	(7.25%)
FY2024	4.6×	0.00%
FY2023	4.6×	—

Period	P/S ratio	Change
Sep 2026	11.5×	(17.79%)
Jun 2026	14.0×	36.98%
Mar 2026	10.2×	140.18%
Dec 2025	4.3×	(7.25%)
4 more quarters	Free account

Against its own ten years

Low 3.3× High 17.5×

Ten-year median 10.7×

Current reading's percentile 75

Company	P/S ratio
RDNT RadNet, Inc. compare	2.7×
NEO NeoGenomics, Inc. compare	2.7×
VCYT Veracyte, Inc. compare	3.3×
SHC Sotera Health Company compare	3.7×
QGEN QIAGEN N.V. compare	5.0×
CDNA CareDx, Inc. compare	8.1×
BLLN BillionToOne, Inc.	12.1×
ADPT Adaptive Biotechnologies Corporation compare	14.5×
GRAL GRAIL, Inc. compare	34.9×
Diagnostics & Research industry median	4.2×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

BillionToOne, Inc. (BLLN) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on BLLN

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on BLLN

Stockrow Weekly